Diagnostics and remote monitoring.
Value-based care pays for what gets caught early. We represent detection and monitoring technology and sell it into the settings where an earlier signal changes what happens next.
The buyer is rarely the champion.
Monitoring technology usually finds a clinical advocate quickly. The advocate rarely controls the budget, and the case has to be rebuilt for whoever does. That handoff is where most diagnostics and monitoring companies lose a year.
Reimbursement exists for remote monitoring, but coding alone doesn't close a health system deal.
Continuous monitoring competes for attention against alarm fatigue that clinical staff already resent.
Integration questions surface late, and an EHR conversation your team can't answer stalls the review.
Screening programs need a workflow owner. Without one named early, adoption plateaus after the pilot.
Readmissions are still the cleanest argument you can make.
Sources: Centers for Medicare & Medicaid Services, Hospital Readmissions Reduction Program; FY2026 IPPS Final Rule.
Technology we carry in this category.
Point-of-care diagnostics
In-clinic screening that turns a routine visit into a detection moment, with a result the clinician can act on the same day.
Remote patient monitoring
Integrated monitoring that extends clinical reach past the facility, including to rural populations existing programs struggle to cover.
Contactless and passive monitoring
Sensors that detect decompensation earlier without asking the patient to do anything, so compliance stops being the variable that decides whether it works.
Preventive screening programs
Screening a practice can offer under its own name, with no new infrastructure to build and no new staff to hire.
Our team already sits in these conversations.
The people carrying your product have called on these accounts for years. They know which committee owns a monitoring decision, which service line will be asked to absorb the workflow, and who has to sign before anything moves. That knowledge is the difference between a meeting and a decision.
Tell us what you're working on.
A real person responds within one business day. If the product is a fit for diligence, we'll tell you what we need to see.